#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic myeloid leukaemia (in remission) Emphysema Alport's syndrome Bronchopulmonary dysplasia Fabry's disease Chronic lymphocytic leukaemia Dent's disease Angiosarcoma recurrent Craniocerebral injury Glioblastoma multiforme Metastatic gastric cancer Congenital myopathy Familial amyotrophic lateral sclerosis KBG syndrome Thalassaemia beta More trials…

    Learn about Rare Diseases

    Encephalitis autoimmune – Treatment Castleman’s disease – Trials in Disease Pulmonary sarcoidosis – Basic Information Rhabdomyosarcoma – Life with Disease Gaucher’s disease type III – Trials in Disease Langerhans cell sarcoma – Diagnostics Rhabdomyosarcoma – Treatment Idiopathic inflammatory myopathy – Treatment Immunodeficiency congenital – Treatment Congenital nephrogenic diabetes insipidus – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sodium Glycerophosphate Caraway Oil Eye103 Proline Cortisone Acetate Serpina1(Human)-Aav8-1 Mva-Hbvac Eptinezumab Atogepant Lbl-007 Rbl007.2 ALG-000184 Menotrophin Vinorelbine Tartrate F510/08 Azd5863 Ly3454738 Methylphenidate Hydrochloride Dazukibart ANTI-GD2-800CW More therapies…

    Learn about Your Condition

    Neonatal anoxia Crohn's disease Proteinuria Radiation skin injury Bacterial prostatitis Infectious pleural effusion Meniscus operation Tympanic membrane perforation Rhabdomyosarcoma Ankylosing spondylitis Renal cell carcinoma stage IV Hypopituitarism Ovarian cancer stage IV Implantation complication Follicular lymphoma stage II More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Richter’s syndrome

  • Study of BGB-16673 in combination with drug therapy for patients with relapsed or refractory B-cell malignancies

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia recurrent
    • Chronic lymphocytic leukaemia refractory
    • Follicular lymphoma stage II
    Investigated Drugs:
    • N-[4-({[(1R,4R)-4-Hydroxy-4-Methylcyclohexyl]Methyl}Amino)-3- Nitrobenzene-1-Sulfonyl]-4-(2-{(2S)-2-[2-(Propan-2-Yl)Phenyl]Pyrrolidin1-Yl}-7-Azaspiro[3.5]Nonan-7-Yl)-2-[(1H-Pyrrolo[2,3-B]Pyridin-5- Yl)Oxy]Benzamide
    • BGB-16673
    • Mosunetuzumab
    Germany Italy Poland

  • Study of Glofitamab with Rituximab or Obinutuzumab and Drug Combination for Untreated Richter’s Syndrome Patients

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Glofitamab
    • Doxorubicin Hydrochloride
    • Obinutuzumab
    France

  • Evaluation of Safety and Efficacy of Zilovertamab Vedotin and Nemtabrutinib in Aggressive and Indolent B-cell Malignancies

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Nemtabrutinib
    • Zilovertamab Vedotin
    Czechia Estonia Germany Ireland Italy Poland +3

  • Study on the Effects of Acalabrutinib in Patients with Chronic Lymphocytic Leukemia, Richter’s Syndrome, or Prolymphocytic Leukemia

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Richter’s syndrome
    • Prolymphocytic leukaemia
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Acalabrutinib
    Italy

  • Study on the Safety and Effectiveness of Venetoclax, Atezolizumab, and Obinutuzumab for Patients with Richter Syndrome from Chronic Lymphocytic Leukemia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Richter’s syndrome
    Investigated Drugs:
    • Atezolizumab
    • Obinutuzumab
    • Venetoclax
    Italy

  • Study of Mosunetuzumab and Drug Combination for Untreated Patients with Richter’s Syndrome

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Richter’s syndrome
    Investigated Drugs:
    • Mosunetuzumab
    • Cyclophosphamide Monohydrate
    • Doxorubicin Hydrochloride
    Spain
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!